Description
Reg. No. G4372 (Act 36/1947)
Swine erysipelas is a notifiable disease in terms of the Animal Diseases Act, 1984 (Act 35 of 1984) and any incidence or suspected incidence of the disease must be reported to the state veterinarian.
An inactivated virus vaccine for the active immunisation of pigs (sows and gilts).
INDICATIONS
For the active immunisation of pigs against reproductive problems associated with parvovirus, erysipelas and Leptospira serovars:
- To reduce clinical signs (skin lesions and fever) of swine erysipelas caused by Erysipelothrix rhusiopathiae, serotypes 1 and 2.
- To reduce transplacental infection, viral load and foetal mortality caused by porcine parvovirus.
- To reduce clinical signs (increase of body temperature and reduction in feed intake or activity), infection and bacterial excretion caused by Leptospira interrogans serogroup Canicola serovar Canicola.
- To reduce clinical signs (increase of body temperature and reduction in feed intake or activity), severity of infection and foetal mortality caused by L. interrogans serogroup Pomona serovar Pomona.
- To reduce infection caused by L. interrogans serogroup Icterohaemorrhagiae serovars Copenhageni and Icterohaemorrhagiae, L. interrogans serogroup Australis serovar Bratislava, L. kirschneri serogroup Grippotyphosa serovars Grippotyphosa and Bananal/ Liangguang, L. weilii serogroup Tarassovi serovar Vughia and L. borgpetersenii serogroup Tarassovi serovar Tarassovi.
IMMUNITY
Onset of Immunity:
E. rhusiopathiae: 3 weeks.
Porcine parvovirus: 10 weeks.
Leptospira serogroups: 2 weeks.
Duration of Immunity:
E. rhusiopathiae: 6 months.
Porcine parvovirus: 12 months.
Leptospira serogroup Australis: 6 months.
Leptospira serogroups Canicola, Icterohaemorrhagiae, Grippotyphosa, Pomona and Tarassovi: 12 months.
COMPOSITION
| Active ingredient | Quantity per 2 mℓ dose |
| E. rhusiopathiae, serotype 2 (strain M2) | ≥ 1 ppd1 |
| Porcine parvovirus (strain 014) | ≥ 130 U2 |
| L. interrogans serogroup Canicola serovar Portland-Vere (strain Ca-12-000) | ≥ 2 816 U2 |
| L. interrogans serogroup Icterohaemorrhagiae serovar Copenhageni (strain Ic-02-001) | ≥ 210 U2 |
| L. interrogans serogroup Australis serovar Bratislava (strain As-05-073) | ≥ 1 310 U2 |
| L. kirschneri serogroup Grippotyphosa serovar Dadas (strain Gr-01-005) | ≥ 648 U2 |
| L. interrogans serogroup Pomona serovar Pomona (strain Po-01-000) | ≥ 166 U2 |
| L. santarosai serogroup Tarassovi serovar Gatuni (strain S1148/02) | ≥ 276 U2 |
1 Pig protective dose as compared to a reference preparation known to be protective in pigs.
2 As determined in the in vitro antigenic mass ELISA potency test.
The vaccine contains 150 mg dl-α-tocopheryl acetate as an adjuvant.
